Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Tretinoin (Retin-A) wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Prescription topical. Hydroquinone is used at 2-4% (often as the triple-combination with a retinoid and a mild corticosteroid), applied to pigmented areas usually at night, in time-limited courses (commonly with treatment breaks) under clinician supervision, always with daily sunscreen. There is no oral or systemic use. Avoid indefinite continuous use because of ochronosis risk. This library does not provide an ingestion protocol.
evening
Hydroquinone 2-4% cream or the triple-combination (with retinoid + mild steroid), under a clinician
Prescription topical: a pea-sized amount of 0.025%-0.1% cream or gel applied to clean, dry skin once nightly. Start low-strength and every-other-night to build tolerance. A prescription drug used under clinician direction — not a supplement regimen.
before-bed
Topical cream or gel, 0.025%-0.1% (prescription)
Throughout
8-12 weeks
Throughout
Months to years
12-24 weeks
12-24 weeks
Months
8-12 weeks
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
Cutis (2003) · Rct · n=641
Two pooled 8-week multicenter randomized investigator-blind trials (n=641) of the triple-combination (tretinoin 0.05% + hydroquinone 4% + fluocinolone 0.01%) vs the three dual pairings
Efficacy and safety of a novel triple combination cream compared to Kligman's trio for melasma: A 24-week double-blind prospective randomized controlled trial.
J Eur Acad Dermatol Venereol (2023) · Rct · n=40
24-week double-blind RCT (n=40) using Kligman's trio (hydroquinone + retinoic acid + corticosteroid) as the active gold-standard comparator
Systematic review of randomized controlled trials on interventions for melasma: an abridged Cochrane review.
J Am Acad Dermatol (2014) · Systematic review
Abridged Cochrane review of 20 RCTs (2125 participants) across 23 melasma treatments
Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study.
JAMA (1988) · Rct
Randomized, double-blind, vehicle-controlled trial of topical tretinoin for photoaged forearm and facial skin
Tretinoin emollient cream: a new therapy for photodamaged skin.
J Am Acad Dermatol (1992) · Rct
Multicenter double-blind vehicle-controlled trial of tretinoin emollient cream for photodamaged skin
Long-term treatment of photoaged human skin with topical retinoic acid improves epidermal cell atypia and thickens the collagen band in papillary dermis.
J Am Acad Dermatol (2005) · Open label
Long-term topical retinoic acid on photoaged human skin assessed histologically
Tretinoin (Retin-A) has a higher evidence score (8/10 vs 7/10) and wins in 2 of 3 categories.
For even skin tone, Hydroquinone has a higher relevance score (85 vs 60).
No known interactions between Hydroquinone and Tretinoin (Retin-A) have been documented in our database. However, always consult a healthcare provider before combining supplements.